Advertisement
YOU ARE HERE: LAT HomeCollectionsIsoprinosine Drug
IN THE NEWS

Isoprinosine Drug

FEATURED ARTICLES
BUSINESS
March 21, 1991 | LESLIE BERKMAN, TIMES STAFF WRITER
Newport Pharmaceuticals International Inc. said Wednesday that it has negotiated a new settlement of shareholder lawsuits accusing the company of having misled investors about the prospects for a drug as a treatment for AIDS-related symptoms. Earlier this month, the Laguna Hills-based company disclosed that it had been forced to withdraw another settlement plan because of opposition by company bondholders.
ARTICLES BY DATE
BUSINESS
July 18, 1991 | CRISTINA LEE, TIMES STAFF WRITER
Newport Pharmaceuticals International Inc. said Wednesday that the Scandinavian licensee of its Isoprinosine drug has decided not to seek approval to market the drug as a pre-AIDS medication to several Western European countries. The Laguna Hills company Wednesday also announced earnings of $290,000 on revenue of $20.9 million for the second quarter, contrasted with a loss of $2.2 million on sales of $14.5 million in the corresponding period last year.
Advertisement
BUSINESS
July 18, 1991 | CRISTINA LEE, TIMES STAFF WRITER
Newport Pharmaceuticals International Inc. said Wednesday that the Scandinavian licensee of its Isoprinosine drug has decided not to seek approval to market the drug as a pre-AIDS medication to several Western European countries. The Laguna Hills company Wednesday also announced earnings of $290,000 on revenue of $20.9 million for the second quarter, contrasted with a loss of $2.2 million on sales of $14.5 million in the corresponding period last year.
BUSINESS
March 21, 1991 | LESLIE BERKMAN, TIMES STAFF WRITER
Newport Pharmaceuticals International Inc. said Wednesday that it has negotiated a new settlement of shareholder lawsuits accusing the company of having misled investors about the prospects for a drug as a treatment for AIDS-related symptoms. Earlier this month, the Laguna Hills-based company disclosed that it had been forced to withdraw another settlement plan because of opposition by company bondholders.
BUSINESS
November 28, 1989 | GREGORY CROUCH, TIMES STAFF WRITER
Newport Pharmaceuticals announced Monday that it is resuming efforts to obtain approval for the sale of Isoprinosine to people infected with the AIDS virus, reversing a decision made a year ago to stop all research and testing on the drug.
BUSINESS
June 20, 1990 | ROBERT STEINBROOK, TIMES MEDICAL WRITER
Interest in an all but forgotten experimental AIDS drug, isoprinosine--manufacturered by Newport Pharmaceuticals International Inc. of Laguna Hills--has been renewed by the New England Journal of Medicine's decision to publish a favorable Scandinavian study of the medication. "Treatment with isoprinosine appears to delay progression to AIDS" in infected individuals, Dr.
BUSINESS
October 2, 1990 | LESLIE BERKMAN, TIMES STAFF WRITER
Newport Pharmaceuticals and its liability insurer have tentatively agreed to pay about $5.7 million to settle two shareholders' lawsuits alleging that the company misled investors in promoting an anti-AIDS drug in 1985 and 1986, the company said Monday. The civil lawsuits, which make identical complaints, were filed separately in state and federal courts in September, 1986.
BUSINESS
June 19, 1990 | From A Times Staff Writer
Newport Pharmaceuticals said Monday that a leading medical journal has agreed to publish a study of the company's drug, Isoprinosine, in the fight against HIV, the virus that causes AIDS. The Laguna Hills-based company said it would release further details Thursday at a press conference at the International AIDS Conference in San Francisco. Newport stock has shot up 66% since Thursday and closed Monday at $2.8125 in over-the-counter trading.
BUSINESS
November 2, 1988 | ERIC SCHINE, Times Staff Writer
Newport Pharmaceuticals International Inc. reported Tuesday a $1.6-million loss for the third quarter. The company said the cost of clinical testing of isoprinosine, a drug believed to slow the advance of the AIDS virus, accounted for most of the loss. The company has said it will probably give up its 14-year battle to get Food and Drug Administration approval to sell the drug in the United States if the tests are disappointing.
BUSINESS
September 25, 1988 | ERIC SCHINE, Times Staff Writer
Newport Pharmaceuticals International is yet another example of an Orange County company with a potentially hot product that has had trouble getting government approval. As a result, the company's stock price has undergone wild gyrations. A few analysts, however, are betting that a new, nearly completed study will provide enough ammunition to allow Newport Pharmaceuticals to submit its isoprinosine drug for Federal Drug Administration review as an AIDS treatment by the end of the year.
BUSINESS
October 2, 1990 | LESLIE BERKMAN, TIMES STAFF WRITER
Newport Pharmaceuticals and its liability insurer have tentatively agreed to pay about $5.7 million to settle two shareholders' lawsuits alleging that the company misled investors in promoting an anti-AIDS drug in 1985 and 1986, the company said Monday. The civil lawsuits, which make identical complaints, were filed separately in state and federal courts in September, 1986.
BUSINESS
June 20, 1990 | ROBERT STEINBROOK, TIMES MEDICAL WRITER
Interest in an all but forgotten experimental AIDS drug, isoprinosine--manufacturered by Newport Pharmaceuticals International Inc. of Laguna Hills--has been renewed by the New England Journal of Medicine's decision to publish a favorable Scandinavian study of the medication. "Treatment with isoprinosine appears to delay progression to AIDS" in infected individuals, Dr.
BUSINESS
June 19, 1990 | From A Times Staff Writer
Newport Pharmaceuticals said Monday that a leading medical journal has agreed to publish a study of the company's drug, Isoprinosine, in the fight against HIV, the virus that causes AIDS. The Laguna Hills-based company said it would release further details Thursday at a press conference at the International AIDS Conference in San Francisco. Newport stock has shot up 66% since Thursday and closed Monday at $2.8125 in over-the-counter trading.
BUSINESS
November 28, 1989 | GREGORY CROUCH, TIMES STAFF WRITER
Newport Pharmaceuticals announced Monday that it is resuming efforts to obtain approval for the sale of Isoprinosine to people infected with the AIDS virus, reversing a decision made a year ago to stop all research and testing on the drug.
BUSINESS
October 2, 1991 | SONNI EFRON, TIMES STAFF WRITER
Newport Pharmaceuticals International Inc., anticipating the first annual profit in its 20-year history, changed its name Tuesday to SysteMed Inc. to reflect its role as a mail-order prescription drug distributor. Newport was founded as a drug company in 1971, but sales of its drug Isoprinosine now account for only 8% of revenues.
Los Angeles Times Articles
|